npj Regenerative Medicine, 2022 · DOI: https://doi.org/10.1038/s41536-022-00209-8 · Published: January 1, 2022
The Hippo pathway is a signaling cascade that regulates cell proliferation, mechanotransduction, stem cell fate, and tumorigenesis. The Hippo pathway effectors Yap/Taz facilitate zebrafish regeneration and that this appears to be latent in mammals. Therapeutically promoting precise and temporal YAP/TAZ signalling in humans may enhance regeneration and hence reduce morbidity. The zebrafish Danio rerio has the potential to completely regenerate multiple adult and embryonic organs, including the heart, fin, and many nervous system compo-nents. The cellular and molecular drivers of zebrafish regeneration have been the subject of intense research. When the Hippo pathway is inactive these phosphorylations do not occur, resulting in YAP1/TAZ nuclear localisation, where they outcompete VGLL4 and bind to transcrip-tion factors TEAD1-4. Binding to TEADs stimulate the expression of a range of pro-proliferative, -oncogenic, -stemness, and -EMT genes, such as CTGF and CYR61.
Promoting precise and temporal YAP/TAZ signaling in humans may enhance regeneration and reduce morbidity.
Pharmacological regulation of the Hippo pathway could modulate CM proliferation and fate plasticity, promoting scarless healing in the adult heart and reducing disease burden.
Enhancing scar resolution, promoting EMT, enhancing CTGF signalling at later stages of regeneration, and identifying CTGF-responsive spinal cord cells may allow for the identification of a therapeutic target to promote mammalian spinal cord regeneration.